Flas, C., Zielonka, M., Dias Da Silva, I., Wuidar, V., & Pequeux, C. (06 March 2026). Impact of menopause treatments on the tumor microenvironment [Paper presentation]. International Society of Gynecological Endocrinology (ISGE). |
Zielonka, M., Flas, C., Wuidar, V., Dias Da Silva, I., Sounni, N. E., & Pequeux, C. (March 2026). Enhancing Breast Cancer Sensitivity to Endocrine Therapies Through Intermittent Estrogen Exposure : A Proof Of Concept [Paper presentation]. The International Society of Gynecologic Endocrinology (ISGE), Rome, Italy. |
Flas, C., Zielonka, M., Dias Da Silva, I., Wuidar, V., & Pequeux, C. (December 2025). Impact of estrogenic and menopause treatments on the microenvironment of ER-negative cancers [Poster presentation]. Tumor Heterogeneity, Plasticity and Therapy (3rd edition). |
Zielonka, M., Wuidar, V., Flas, C., Dias Da Silva, I., Sounni, N. E., Jerusalem, G., & Pequeux, C. (December 2025). Is it possible to enhance the sensitivity of resistant breast cancer to endocrine therapies with pulsed estrogen-based treatment ? [Poster presentation]. Tumor Heterogeneity, Plasticity and Therapy (3rd edition), Louvain, Belgium. |
Flas, C., Zielonka, M., Dias Da Silva, I., Wuidar, V., & Pequeux, C. (24 October 2025). Impact of estrogenic and menopause treatments on the microenvironment of ER-negative cancers [Poster presentation]. Belgian association for cancer research (BACR). |
Zielonka, M., Flas, C., Wuidar, V., Dias Da Silva, I., & Pequeux, C. (October 2025). Pulsed Estrogen Therapy : A promising Strategy to Restore Endocrine Sensitivity in Breast Cancer [Poster presentation]. Belgian Association for Cancer Research (BACR), Louvain, Belgium. |
Flas, C., Zielonka, M., Dias Da Silva, I., Wuidar, V., & Pequeux, C. (12 September 2025). Impact of estrogenic and menopause treatments on the microenvironment of ER-negative cancers [Poster presentation]. GIGA Day 2025. |
Flas, C., Zielonka, M., Dias Da Silva, I., Wuidar, V., & Pequeux, C. (22 May 2025). Assessing the effects of estrogenic and menopause treatments on the microenvironment in ER-negative cancers [Poster presentation]. Annual meeting of the Namur Cancer Research Pole. |
Flas, C., Zielonka, M., Dias Da Silva, I., Wuidar, V., & Pequeux, C. (09 May 2025). Assessing the effects of estrogenic and menopause treatments on the microenvironment in ER-negative cancers [Poster presentation]. Second edition of the yBIS annual meeting. |
Flas, C., Dias Da Silva, I., Wuidar, V., Zielonka, M., Staumont, B., Nisolle, M., & Pequeux, C. (24 April 2025). Deciphering the molecular signaling of the estrogenic treatments and their analogues on the human endometrium for safer hormonal treatments [Poster presentation]. 5th Belgian Society for Animal Cell Technology (BELSACT) Scientific Meeting. |
Zielonka, M., Wuidar, V., Dias Da Silva, I., Flas, C., Nizet, C., & Pequeux, C. (24 April 2025). Human breast organoids, from healthy to cancerous tissues : a model to assess the impact of menopausal hormone therapy [Paper presentation]. the BELgian Society for Animal Cell Technology (BELSACT). |
Wuidar, V., Dias Da Silva, I., Zielonka, M., Flas, C., Staumont, B., & Pequeux, C. (29 January 2025). Transient Activation of ERα by Pulsed Estrogen Treatments Prevent the Growth of Breast Cancer [Poster presentation]. Séminaire Télévie 2025, Liège, Belgium. |
Wuidar, V., Dias Da Silva, I., Zielonka, M., Flas, C., Staumont, B., & Pequeux, C. (23 September 2024). Prevention of Breast Cancer Growth: A Complex Interplay Between Estrogen Receptor Activation and Estrogen Nature [Poster presentation]. EMBO Workshop: Nuclear Receptors: No Disease is Safe, Cavtat, Croatia. |
Wuidar, V., Dias Da Silva, I., Zielonka, M., Flas, C., & Pequeux, C. (06 February 2024). Does pulsed natural estrogen reduce breast cancer risk? [Poster presentation]. Séminaire Télévie 2024. |